EVAHF
EGF Theramed Health Corp.
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.02
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.02
Prev close
0.02
Day high
0.03
Day low
0.03
Volume
138
Market cap
—
P/E (TTM)
—
52W range
0.02 – 0.18
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
-26.67%
-30.4%
3M
-75.28%
-78.4%
6M
-48.84%
-59.9%
YTD
-43.59%
-55.9%
1Y
-62.71%
-82.7%
3Y
-90.18%
-164.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Selling, general & admin | $113.46K | $175.57K | $433.54K | $630.65K | -35.4% |
| Total operating expense | $274.50K | $239.63K | $567.35K | $989.06K | +14.6% |
| Operating income | -$274.50K | -$239.63K | -$567.35K | -$989.06K | -14.6% |
| Net interest income | -$2.19M | -$57.62K | -$38.76K | -$15.13K | -3,698.7% |
| Pre-tax income | -$2.40M | -$296.26K | -$643.48K | -$1.36M | -709.2% |
| Tax provision | $832.06K | $0 | — | — | — |
| Net income | -$3.21M | -$269.25K | -$623.00K | -$1.35M | -1,090.8% |
| Net income to common | -$3.21M | -$269.25K | -$623.00K | -$1.35M | -1,090.8% |
| Basic EPS | -0.28 | -0.02 | -0.06 | -0.63 | -1,300.0% |
| Diluted EPS | -0.28 | -0.02 | -0.06 | -0.63 | -1,300.0% |
| EBIT | -$209.21K | -$239.53K | -$605.86K | -$1.35M | +12.7% |
| EBITDA | -$209.21K | -$239.53K | -$605.86K | -$1.35M | +12.7% |
| Basic shares | 11.60M | 11.21M | 9.99M | 2.16M | +3.4% |
| Diluted shares | 11.60M | 11.21M | 9.99M | 2.16M | +3.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $13.79K | $9.79K | $11.50K | $15.02K | +40.8% |
| Cash & short-term investments | $14.01K | $10.01K | $11.72K | $15.23K | +40.0% |
| Total current assets | $19.34K | $211.41K | $190.69K | $175.67K | -90.9% |
| Goodwill & intangibles | — | — | — | $0 | — |
| Total assets | $22.34K | $214.41K | $193.69K | $178.67K | -89.6% |
| Total current liabilities | $2.99M | $2.92M | $2.67M | $1.67M | +2.5% |
| Current debt | $988.02K | $997.83K | $919.66K | $840.38K | -1.0% |
| Long-term debt | — | — | $919.66K | $840.38K | — |
| Total debt | $1.51M | $1.47M | $1.34M | $1.22M | +2.5% |
| Total liabilities | $5.93M | $2.92M | $2.67M | $2.51M | +103.3% |
| Retained earnings | -$59.28M | -$56.08M | -$55.81M | -$55.18M | -5.7% |
| Shareholder equity | -$4.52M | -$1.34M | -$1.14M | -$1.02M | -237.6% |
| Working capital | -$2.97M | -$2.71M | -$2.48M | -$1.49M | -9.8% |
| Net tangible assets | -$4.52M | -$1.34M | -$1.14M | -$1.02M | -237.6% |
| Shares issued | 11.62M | 11.39M | 10.49M | 2.16M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$3.23M | -$296.26K | -$643.48K | -$1.36M | -990.1% |
| Stock-based compensation | — | — | — | $0 | — |
| Change in working capital | $318.13K | $68.03K | $19.74K | -$3.71K | +367.7% |
| Operating cash flow | $29.75K | -$134.71K | -$576.01K | -$993.42K | +122.1% |
| Investing cash flow | — | — | — | $0 | — |
| Financing cash flow | -$25.75K | $133.00K | $572.50K | $306.02K | -119.4% |
| Free cash flow | $29.75K | -$134.71K | -$576.01K | -$993.42K | +122.1% |
| End cash position | $13.79K | $9.79K | $11.50K | $15.02K | +40.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Selling, general & admin | $55.15K | $40.15K | $17.97K | -$92.37K | $40.52K | — | +37.4% |
| Total operating expense | $83.12K | $60.04K | $32.39K | $9.23K | $60.93K | — | +38.4% |
| Operating income | -$83.12K | -$60.04K | -$32.39K | -$9.23K | -$60.93K | — | -38.4% |
| Net interest income | -$40.52K | -$20.80K | -$18.02K | -$2.15M | -$14.49K | — | -94.8% |
| Pre-tax income | -$124.53K | -$72.23K | -$61.31K | -$2.07M | -$74.96K | — | -72.4% |
| Tax provision | $0 | $0 | — | $827.69K | $0 | $4.37K | — |
| Net income | -$110.98K | -$69.69K | -$49.37K | -$2.90M | -$69.94K | — | -59.2% |
| Net income to common | -$110.98K | -$69.69K | -$49.37K | -$2.90M | -$69.94K | — | -59.2% |
| Basic EPS | -0.01 | -0.01 | -0.00 | — | -0.01 | -0.02 | 0.0% |
| Diluted EPS | -0.01 | -0.01 | -0.00 | — | -0.01 | -0.02 | 0.0% |
| EBIT | -$84.32K | -$51.68K | -$43.36K | $78.16K | -$60.49K | — | -63.2% |
| EBITDA | -$84.32K | -$51.68K | -$43.36K | $78.16K | -$60.49K | — | -63.2% |
| Basic shares | 11.62M | 11.62M | 11.62M | — | 11.62M | 11.62M | 0.0% |
| Diluted shares | 11.62M | 11.62M | 11.62M | — | 11.62M | 11.62M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.68K | $10.25K | $13.69K | $13.79K | $23.80K | +4.2% |
| Cash & short-term investments | $10.90K | $10.47K | $13.90K | $14.01K | $24.02K | +4.1% |
| Total current assets | $16.06K | $15.25K | $19.61K | $19.34K | $34.11K | +5.3% |
| Total assets | $19.06K | $18.25K | $22.61K | $22.34K | $37.11K | +4.5% |
| Total current liabilities | $6.11M | $6.06M | $5.99M | $2.99M | $3.05M | +0.9% |
| Current debt | $1.09M | $1.08M | $1.02M | $988.02K | $983.98K | +0.7% |
| Total debt | $1.66M | $1.63M | $1.56M | $1.51M | $1.51M | +1.8% |
| Total liabilities | $6.11M | $6.06M | $5.99M | $5.93M | $3.05M | +0.9% |
| Retained earnings | -$59.44M | -$59.40M | -$59.33M | -$59.28M | -$56.38M | -0.1% |
| Shareholder equity | -$4.68M | -$4.64M | -$4.57M | -$4.52M | -$1.62M | -0.9% |
| Working capital | -$6.10M | -$6.05M | -$5.97M | -$2.97M | -$3.02M | -0.9% |
| Net tangible assets | -$4.68M | -$4.64M | -$4.57M | -$4.52M | -$1.62M | -0.9% |
| Shares issued | 11.62M | 11.62M | 11.62M | 11.62M | 11.62M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$52.30K | -$72.23K | -$61.31K | -$2.89M | -$74.96K | +27.6% |
| Change in working capital | $23.57K | -$4.15K | $8.35K | $8.11K | $64.80K | +667.8% |
| Operating cash flow | $428 | -$64.44K | -$24.11K | -$10.01K | $3.85K | +100.7% |
| Financing cash flow | $0 | $61.00K | $24.00K | $0 | $0 | -100.0% |
| Free cash flow | $428 | -$64.44K | -$24.11K | -$10.01K | $3.85K | +100.7% |
| End cash position | $10.68K | $10.25K | $13.69K | $13.79K | $23.80K | +4.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.02
+0.00% from price
SMA 20
0.03
-12.70% from price
SMA 50
0.03
-34.91% from price
SMA 100
0.06
-64.92% from price
SMA 200
0.05
-59.98% from price
EMA 12
0.02
-4.83% from price
EMA 26
0.03
-19.44% from price
EMA 50
0.04
-41.01% from price
RSI (14)
15.3
Oversold
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
2.60% of price
Realised vol 30D
88.4%
Annualised
Bollinger upper
0.03
20, 2σ
Bollinger lower
0.02
20, 2σ
50 / 200 cross
Death
0.03 vs 0.05
Trend bias
Below 200
-59.98%
Risk profile
Beta vs SPY
0.47
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
88.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-87.4%
Peak to trough
Max drawdown 5Y
-99.3%
Peak to trough
ATR 14
0.00
2.60% of price
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.